Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Europe developing roadmap for mHealth use and acceptance

EU's MovingLife project is currently consulting on mHealth needs and requirements

Europe authorities are developing a roadmap for mHealth solutions to ensure the technology gains widespread use and acceptance.

The EU-funded MovingLife Project is currently running a public consultation on the plans, focusing on the most important needs and requirements authorities will have to satisfy “in order to facilitate the deployment of mHealth solutions”.

It will address a broad range of issues, including technology options for mHealth applications and services; options for new and improved medical guidelines; user empowerment, acceptance, ethics and privacy; socio-economic environments and policy and regulatory frameworks.

The consultation will be used to revise and fine-tune a set of preliminary roadmaps into a consolidated roadmap for mHealth in Europe.

This final roadmap, and an action plan for its incorporation, will be presented and discussed at a stakeholder conference in Brussels in early 2013.

Earlier this year a report by mobile operators' association GSMA and consultants PwC concluded that mobile technology will be a key enabler of healthcare delivery, reaching every corner of the globe by 2017.

The research also predicted that within the next five years Europe will be the most significant sales region for mHealth technology (accounting for $6.9bn in related revenues), closely followed by Asia Pacific ($6.8bn) and North America ($6.5bn).

• The MovingLife Project's Roadmaps for Mobile Healthcare consultation runs until on September, 17

11th September 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

How to get management buy-in for content marketing
Pharma content marketing is still fairly new in the scheme of things for the pharma industry. In the conservative and traditional pharma industry that’s fraught with regulations, getting management buy-in...
EY Life Sciences Sector Update
Asia-Pacific and Japan...
A roadmap to strategic drug pricing
The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. Pharma firms must identify products that will benefit from innovative pricing models, and then forge...

Infographics